13% Growth Masks a Margin Squeeze Under Tariff Fire
Consolidated revenue grew 13% YoY and EBITDA surged 48%, but operating margins stalled while tariffs and wage costs ate into profit. The FY27 15%+ guidance now hinges on H2 recovery that has yet to arrive.
₹1,113 Cr
+13% YoY
+48%
YoY
9.4%
flat YoY, 1.3pp hedge-aided
₹41.2 Cr
-6.9% QoQ; low base distorts YoY
Gokaldas Exports delivered solid top-line growth (13% consolidated, Africa 32% YoY), and EBITDA expanded 48% year-on-year. But the bottom line tells a different story: profit fell 6.9% quarter-on-quarter despite revenue down only 3.5%, and margins stalled at 9.4% operating profitability — flat versus Q1. The culprit: tariff headwinds and wage cost inflation are compressing earnings faster than the company can pass them through to customers. Reported PAT of ₹41.2 Cr carries an asterisk: it's built on a weak Q2 FY26 base (tariff-hit last year), inflating the 410% YoY comparison.
The margin lie — growth that doesn't flow through
Here's the tension: 48% EBITDA growth but zero margin expansion. If EBITDA grew 48% but revenue grew only 13%, margins should have expanded 3+ points. They didn't. The reason: a 1.3 percentage point benefit from INR hedging masked an underlying margin decline. Back out that hedge gain, and Q2 operating margins would have been ~8.1%, down from Q1's 9.4%. Tariffs (US 12.5% on India apparel) and wage inflation in Bangladesh (up 50% over 3 years) are eating the upside. Africa 32% YoY growth is real, but it arrived at seasonally low 40% utilization and margin compression due to customer mix.
An inflationary environment with oil prices being high is creating a situation where Bangladesh workers tend to push for higher wages.
Net profit fell 6.9% quarter-on-quarter despite a modest revenue decline, confirming cost pressures are translating directly to the bottom line. Net profit margin compressed to 3.6% from a typical 5-7%, a warning flag that the business is struggling to absorb inflation without cutting volumes or accepting lower margins.
Management claims: what holds up, what doesn't
India business grew 10% YoY in seasonally weak Q2
Consolidated 13% + Africa 32% implies India ~10%
Supported
Africa delivered 32% YoY growth with improved realizations
Annualized ₹250–300 Cr (~₹190 Cr prior = 31–58% growth); utilization 40% (seasonal low)
Supported, but seasonality real
EBITDA rose 48% YoY
9.4% OPM vs ~6.3% prior = 48% growth ✓
Supported
FY27 consolidated growth 15%+ remains on track
Q2 at 13%; H2 needs 17%+ avg to hit 15%+ full year
Overstated — now challenged
Africa FY27 revenue guidance ₹500–650 Cr ($60–78M)
Current run-rate ~₹250 Cr ($30M); visibility to $60M Q3–Q4 suggests ₹550–650 Cr annualized
Tracking upward; contingent on seasonal ramp
What changed on this call
BTPL margin target walked down: From 'mid-to-high single-digit EBITDA margin by Q4' to 'PBT breakeven' (near zero). The Bombay Rayon textile assets acquired are proving harder to integrate; Q2 EBITDA was slightly negative. Management now targets Q4 revenue ₹250 Cr at PBT breakeven, with realistic 10% EBITDA margin by FY28 — a delay of 4+ quarters versus prior expectations. Legal challenges (Bombay Rayon investigation) are still pending but management expects clearance within 10 days.
Capex guidance raised: From ₹100 Cr (for FY27) to ₹150 Cr this year and ₹175 Cr next. This signals management's decision to accelerate factory buildouts (Bhopal phase 2, Ranchi 1,000-machine factory, brownfield debottlenecking) ahead of prior plan. The ambition is ₹4,000 Cr revenue capacity by FY29 (3x current), backed by structural capex of ₹150–200 Cr/year. The raise suggests prior guidance underestimated the pace needed to defend competitive position as Bangladesh wages rise and FTAs shift order flows.
Africa FY27 revenue guided upward: Prior range ₹500–650 Cr ($60–78M); current management commentary suggests full-year tracking ₹550–650 Cr if Q3–Q4 seasonal strength holds. New Kenya customers are starting FY28, adding modest revenue contribution and gradual de-risking of the 20–25% single-customer concentration.
Consolidated 13% growth in a weak quarter shows resilience
Africa 32% YoY growth breaking through tariff headwinds and seasonal weakness
Capex expansion and new factories (Ranchi, Bhopal) have concrete timelines and multi-year visibility
Net debt down ₹124 Cr YoY; deleveraging on track despite M&A
OPM flat at 9.4% despite 48% EBITDA growth signals margin pressure, not expansion
PAT down 6.9% QoQ despite modest revenue decline shows cost absorption without pricing power
FY27 15%+ growth now requires 17%+ H2 growth — unrealistic after weak Q2 (13%)
BTPL margin recovery delayed and legal challenges still pending
1.3pp hedge benefit masks underlying margin deterioration; Q3–Q4 reversal will be headwind
FY27 15%+ growth guidance requires 17%+ H2 growth; tariff/macro headwinds could force miss
HighQ2 delivered 13%; no formal cut yet, but contingency is real. Tariff clarity and retail demand softness are wildcards. Miss would break confidence in management's forecasting and trigger multiple compression.
Margin stagnation: OPM flat despite 48% EBITDA growth signals pricing-power loss
HighIf EBITDA grows but margins stay flat, the leverage is missing. Tariff pass-through is failing; cost inflation is winning. Without margin recovery to 10%+, 15%+ growth is mostly a volume story with limited profit leverage.
BTPL integration complexity: legal challenges (Bombay Rayon) and margin recovery slower than hoped
HighBTPL margin target cut from mid-single digits to near-zero by Q4. Q2 EBITDA slightly negative. If legal issues escalate or integration drags, BTPL becomes a drag on consolidated growth rather than a catalyst.
Africa customer concentration: 20–25% of revenue from one large customer; de-risking gradual
MediumOne customer is seasonal (Q2–H2 heavy, pre-summer). If this customer defers or consolidates suppliers, Africa growth stalls. De-risking (two new Kenya customers starting FY28) is phased over quarters.
Exchange hedge reversal: 1.3pp margin benefit in Q2 becomes headwind in Q3–Q4 as INR weakens to 93-94
MediumQ2 OPM 9.4% includes hedge gain; underlying was 8.1%. As hedge resets, margins face ~1.3pp headwind. Adds to tariff/wage pressure already in place. Q3–Q4 OPM could fall below 8%.
Bangladesh wage inflation and unrest: 50% wage rise over 3 years, LDC status expires Nov 2029
MediumBangladesh still competitive at current wages, but unrest risk is real. If escalates, could force order shift to India/Vietnam. India-UK/EU FTAs reduce Bangladesh dependency, but transition costs exist and timing is uncertain.
How the street is positioned
Price and trend: At ₹713.95, Gokaldas is trading 43.4% below its all-time high and 34.5% above its 52-week low. The stock sits above its SMA20 (₹681.78) and SMA50 (₹700.69) but below SMA200 (₹721.96), signaling a mild uptrend trapped in a drawn-down valuation zone. RSI at 55.2 is neutral — no oversold or overbought signal. Volume is normal. The market is cautious, not panicking, but not yet convinced of a rebound.
Ownership flows — the red flag: FII ownership has collapsed from 24.89% (Q1 FY26) to 13.42% (Q2 FY27), a drop of 11.5 percentage points. DII has stepped in, rising from 37.17% to 44.78% (+7.6pp). The narrative: foreign investors are exiting on execution risk (guidance contingency, margin pressure, tariff headwinds), and domestic money is adding at the discount. A bulk buy by SBI Life Insurance (4L shares @ ₹814.79 in June 2026) suggests some institutional confidence, but this is not enough to offset the FII exodus. The ownership rotation from FII to DII is a tell: skepticism on near-term guidance realization.
The reconciliation: Fundamentals align with price action and flows. This is not a "hated and cheap" opportunity — it's a "challenged execution" story where the market is right to be cautious. The drawdown is justified by margin pressure, guidance contingency, and FII skepticism. A rebound requires proof of: (1) H2 growth >17%, (2) OPM expansion to >10%, (3) BTPL breakeven confirmed, (4) tariff pass-through clarity. Until then, the stock should trade at a discount to history.
1 · Q3 FY27 revenue and margin (due ~January 2027)
The make-or-break metric. Must show >17% YoY growth to keep 15%+ FY27 guidance credible. OPM must expand to >10% (or >9.5% at minimum) as Africa seasonally ramps and BTPL absorbs fixed costs. If Q3 shows <15% growth or OPM <9%, FY27 guidance misses and re-rating is sharp downward.
2 · BTPL Q4 breakeven confirmation and PBT/EBITDA split
Management is targeting Q4 revenue ₹250 Cr at PBT breakeven (near-zero EBITDA). If materialized, it signals integration is on track and margin recovery for FY28 is achievable. If Q4 shows EBITDA still negative or PBT loss, integration risk escalates and FY28 guidance credibility suffers.
3 · FY28 India and Africa margin guidance (February 2027 concall)
Realism check. Management is guiding India 13% EBITDA margin and Africa 10% by FY28. If early commentary in Q4 results is cautious (lowered margins, extended timelines, reduced capex), it means Q3–Q4 margin recovery is fading and long-term targets are at risk.
Gokaldas Exports is executing a real long-term story — ₹4,000 Cr capacity, tariff-driven order shift to India, new geographies (Kenya). But Q2 FY27 revealed the near-term friction: margins are not expanding despite strong EBITDA growth, profit is decelerating quarter-on-quarter, and FY27 guidance is now contingent on a recovery that has yet to arrive. The company is not broken, but it is slowing — and the street's skepticism (FII exits, drawdown valuation, OPM stagnation) is warranted.
The number to track from here is operating margin. If OPM expands to 10%+ in H2 FY27 (despite the hedge reversal headwind), the thesis resets to 'recovery confirmed' and multiple re-rating follows. If OPM stays below 9%, the thesis becomes 'margin squeeze persists' and FY27 growth is mostly a volume story with no profit leverage — a disappointment that justifies the current drawdown. Hold — wait for H2 to show margin recovery before re-engaging.
Informational and educational content only. Not investment advice.